MiNK Therapeutics' (NASDAQ: INKT) Breakthrough Treatment: Unveiling the Potential of agenT-797 for Immunocology
Experienced a significant surge in its stock shares, soaring by an additional 22% on June 22, 2023.
Source: microcapdaily.com
Stay updated with breaking news from Players Utilizing The Potential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experienced a significant surge in its stock shares, soaring by an additional 22% on June 22, 2023.